4.3 Article

Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial

期刊

JOURNAL OF SEXUAL MEDICINE
卷 5, 期 2, 页码 476-484

出版社

ELSEVIER SCI LTD
DOI: 10.1111/j.1743-6109.2007.00700.x

关键词

erectile dysfunction; penile erection; prostatectomy; sildenafil citrate

向作者/读者索取更多资源

Introduction. After bilateral nerve-sparing radical retropubic prostatectomy (BNSRRP), nocturnal and sexually mediated erections may help to preserve normal erectile function (EF). Aim. To investigate nocturnal penile tumescence and rigidity (NPTR) in a subset (N = 54 men) from a randomized, double-blind trial (N = 76) of nightly sildenafil after BNSRRP. Methods. Inclusion required preoperative normal EF (defined as a combined score of >= 8 for International Index of Erectile Function questions 3 (penetration) and 4 (maintained erection after penetration) and NPTR testing ( >= 10 continuous minutes of >= 55% rigidity [R >= 55%] at the base). Postoperative assessments were at weeks 4 (pretreatment), 16, 28, 40 (during 36 weeks of nightly prophylaxis: sildenafil 50 mg [N = 17], 100 mg [N = 18] or placebo [N = 19]), and 48 (after 8 weeks of no erectile dysfunction therapy, when responders were delineated by the defined normal EF and a yes response to Over the past 4 weeks, have your erections been good enough for satisfactory sexual activity?). Base and tip rigidity and tumescence were measured using penile plethysmography. Main Outcome Measures. Duration of R 55% and area under the curves for rigidity and tumescence. Results. Postoperatively, rapid profound reduction in nocturnal EF was noted in all groups. There was a gradual dose-dependent improvement in base and tip rigidity in the sildenafil groups but little improvement in the placebo group. Eight weeks after treatment termination (48 weeks postoperatively), 24% (4/17) of 50-mg sildenafil recipients, 3 3 % (6/18) of 100-mg sildenafil recipients, and 5 % (1/19) of placebo recipients were responders. Tip R >= 55% was the most discriminating NPTR measure between nonresponders and responders to sildenafil, in whom it regained baseline (preoperative) levels (whereas base R >= 55% did not). It was most prolonged in responders to sildenafil 100 mg. Conclusions. In our subset analysis, nightly sildenafil for 9 months post-BNSRRP objectively improved nocturnal erections and pharmaceutically unassisted EF.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据